Zahedan Journal of Research in Medical Sciences
The Official Journal of Zahedan University of Medical Sciences
Outlines
Efficacy of Venlafaxine and Methylphenidate in the Treatment of Children with Attention Deficit Hyperactivity Disorder
Author(s):
1Dept of Psychology, Faculty of Medicine, Zahedan University of Medical Sciences and Health Services, Zahedan, Iran
2Behavior Research Center, Shahid Beheshti University of Medical Sciences and Health Services, Teharn, Iran
3Dept of Psychology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences and Health Services, Teharn, Iran
4Neurology Research Center, Shahid Beheshti University of Medical Sciences and Health Services, Teharn, Iran
*Corresponding Author: Behavior Research Center, Shahid Beheshti University of Medical Sciences and Health Services, Teharn, Iran Email: [email protected]
Published online:Jun 26, 2003
Article type:Research Article
Received:May 23, 2003
Accepted:Jun 24, 2003
How to Cite:Firoozkoohi moghaddam M, Arabgol F, Rajezi S, Shams J. Efficacy of Venlafaxine and Methylphenidate in the Treatment of Children with Attention Deficit Hyperactivity Disorder. Zahedan J Res Med Sci. 2003;5(2):e95139. doi:
Abstract
Background : The role of noradrenergic system is strongly considered in etiology and treatment of attention deficit hyperactivity disorder (ADHD). Regarding the role of norepinephrin and serotonin neurotransmitters in activity and attention control processes, this study was performed to compare effectiveness of venlafaxine and methylphenidate in the treatment of ADHD.
Materials and Methods: Forty children with ADHD (aged 6-12) were randomly allocated to receive venlafaxine or methylphenidate in a 6-week clinical trial in Emam-Hossein Hospital. There were no significant differences between groups for age, weight, type and severity of the disorder. Based on DSM-IV criteria and ADHD Rating Scale, patients were diagnosed as having combined and inattentive types of ADHD. Treatment outcome was assessed using parent and teacher versions of ADHD Rating Scale in weeks 2, 4 and 6.
Results: There was a statistically significant decrease in ADHD Rating Scale scores and clinical improvement in each group and there was significant difference between the two groups. The most common adverse effects in venlafaxine group were nausea, sedation, dry mouth and dizziness.
Conclusion: Venlafaxine is effective in the treatment of children with ADHD and could be used as a safe drug in these children through further studies with greater sample sizes are needed to confirm these results.
References
- 1.The References of this article are available on the PDF file.
Copyright
© 2003, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
26
Jun
2008
Efficacy of Venlafaxine and Methylphenidate in the Treatment of Children with Attention Deficit Hyperactivity Disorder
Mahboubeh Firoozkoohi,
fariba Arabgol,
Sepideh Rajezi,
j Shams
Firoozkoohi M, Arabgol F, Rajezi S, Shams J. Efficacy of Venlafaxine and Methylphenidate in the Treatment of Children with Attention Deficit Hyperactivity Disorder. Zahedan J Res Med Sci. 2008;10(2):e94541. doi:
6
Jun
2023
Atomoxetine Versus Combination of Methylphenidate Plus Fluoxetine for Management of Anxiety Disorders in ADHD Children: A Randomized Clinical Trial
Afsaneh Karbasi,
Shahrzad Aghili
Karbasi A, Aghili S. Atomoxetine Versus Combination of Methylphenidate Plus Fluoxetine for Management of Anxiety Disorders in ADHD Children: A Randomized Clinical Trial. Iran J Psychiatry Behav Sci. 2023;17(2):e135121. doi: https://doi.org/10.5812/ijpbs-135121
21
Feb
2015
Risperidone Versus Methylphenidate in Treatment of Preschool Children With Attention-Deficit Hyperactivity Disorder
Fariba Arabgol,
Leily Panaghi,
Vahid Nikzad
Arabgol F, Panaghi L, Nikzad V. Risperidone Versus Methylphenidate in Treatment of Preschool Children With Attention-Deficit Hyperactivity Disorder. Inn J Pediatr. 2015;25(1):-. doi: https://doi.org/10.5812/ijp.265
4
Dec
2021
Analysis of Association Between the Effects of Methylphenidate and DRD4 Gene Polymorphisms in Patients with Attention Deficit Hyperactivity Disorder
Shahrokh Amiri,
Sara Farhang,
Mahmoud Shekari Khaniani,
Sima Mansouri Derakhshan,
Aziz Zadfattah,
Zahra Mohammadi Bina
,et al.Amiri S, Farhang S, Shekari Khaniani M, Mansouri Derakhshan S, Zadfattah A, et al. Analysis of Association Between the Effects of Methylphenidate and DRD4 Gene Polymorphisms in Patients with Attention Deficit Hyperactivity Disorder. J Compr Ped. 2021;12(4):e109377. doi: https://doi.org/10.5812/compreped.109377
30
Dec
2014
Comparison of Therapeutic Effects of Omega-3 and Methylphenidate (Ritalin®) in Treating Children With Attention Deficit Hyperactivity Disorder
Naser Dashti,
Hoda Hekmat,
Hamid Reza Soltani,
Abolghasem Rahimdel,
Mohammad Javaherchian
Dashti N, Hekmat H, Soltani HR, Rahimdel A, Javaherchian M. Comparison of Therapeutic Effects of Omega-3 and Methylphenidate (Ritalin®) in Treating Children With Attention Deficit Hyperactivity Disorder. Iran J Psychiatry Behav Sci. 2014;8(4):. doi:
Download PDF548.42 KB
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles